Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

IntroductionDespite the current effective treatments for acute promyelocytic leukemia (APL), early mortality (EM), defined as death within 30 days of presentation, is a major hurdle to long-term survival.MethodsWe performed a multicenter retrospective study to evaluate the incidence and clinical cha...

Full description

Bibliographic Details
Main Authors: Suhyeon Kim, Jiye Jung, Seo-Yeon Ahn, Mihee Kim, So Yeon Jeon, Chang-Hoon Lee, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Byung-Soo Kim, Hyeoung-Joon Kim, Jae-Yong Kwak, Yong Park, Jae-Sook Ahn, Ho-Young Yhim
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
acute promyelocytic leukemia
all-trans retinoic acid
early mortality
prognosis
risk stratification
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1307315/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1307315/full

Similar Items